Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Scott

Showing results (301-310 of 316) with videos related to

Pageof 32
Sort By:
European Journal of Medical Research|February 28, 1998
In vivo proton magnetic resonance spectroscopy in polymyositis and dermatomyositis: a preliminary studyY L Chung, E C Smith, S C Williams, et al.
Scandinavian Journal of Rheumatology|July 27, 2001
Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazineA Larsen, T K Kvien, M Schattenkirchner, et al.
British Journal of Rheumatology|April 1, 1989
Combination therapy with gold and hydroxychloroquine in rheumatoid arthritis: a prospective, randomized, placebo-controlled studyD L Scott, P T Dawes, E Tunn, et al.
Annals of the Rheumatic Diseases|October 1, 1992
Keratan sulphate in rheumatoid arthritis, osteoarthritis, and inflammatory diseasesT D Spector, L Woodward, G M Hall, et al.
European Journal of Rheumatology and Inflammation|January 1, 1992
Enteric coated naproxen; a double blind trial comparing the tolerance of enteric coated and standard formulationsE C Huskisson, R M Bernstein, J S Coppock, et al.
The Journal of Rheumatology|September 12, 2001
Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study GroupJ R Kalden, D L Scott, J S Smolen, et al.
Annals of the Rheumatic Diseases|September 15, 2001
Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazineD L Scott, J S Smolen, J R Kalden, et al.
Arthritis and Rheumatism|August 6, 2005
Muscle metabolites, detected in urine by proton spectroscopy, correlate with disease damage in juvenile idiopathic inflammatory myopathiesY-L Chung, L G Rider, J D Bell, et al.
Clinical and Experimental Rheumatology|July 10, 2002
Treating rheumatoid arthritis early with disease modifying drugs reduces joint damage: a randomised double blind trial of sulphasalazine vs diclofenac sodiumE H S Choy, D L Scott, G H Kingsley, et al.
Rheumatology (Oxford, England)|June 27, 2001
WHO Collaborating Centre consensus meeting on anti-cytokine therapy in rheumatoid arthritisP Emery, J Y Reginster, T Appelboom, et al.
Pageof 32

Showing results (301-310 of 316) with videos related to

Sort By:
Pageof 32
European Journal of Medical Research|February 28, 1998
In vivo proton magnetic resonance spectroscopy in polymyositis and dermatomyositis: a preliminary studyY L Chung, E C Smith, S C Williams, et al.
Scandinavian Journal of Rheumatology|July 27, 2001
Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazineA Larsen, T K Kvien, M Schattenkirchner, et al.
British Journal of Rheumatology|April 1, 1989
Combination therapy with gold and hydroxychloroquine in rheumatoid arthritis: a prospective, randomized, placebo-controlled studyD L Scott, P T Dawes, E Tunn, et al.
Annals of the Rheumatic Diseases|October 1, 1992
Keratan sulphate in rheumatoid arthritis, osteoarthritis, and inflammatory diseasesT D Spector, L Woodward, G M Hall, et al.
European Journal of Rheumatology and Inflammation|January 1, 1992
Enteric coated naproxen; a double blind trial comparing the tolerance of enteric coated and standard formulationsE C Huskisson, R M Bernstein, J S Coppock, et al.
The Journal of Rheumatology|September 12, 2001
Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study GroupJ R Kalden, D L Scott, J S Smolen, et al.
Annals of the Rheumatic Diseases|September 15, 2001
Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazineD L Scott, J S Smolen, J R Kalden, et al.
Arthritis and Rheumatism|August 6, 2005
Muscle metabolites, detected in urine by proton spectroscopy, correlate with disease damage in juvenile idiopathic inflammatory myopathiesY-L Chung, L G Rider, J D Bell, et al.
Clinical and Experimental Rheumatology|July 10, 2002
Treating rheumatoid arthritis early with disease modifying drugs reduces joint damage: a randomised double blind trial of sulphasalazine vs diclofenac sodiumE H S Choy, D L Scott, G H Kingsley, et al.
Rheumatology (Oxford, England)|June 27, 2001
WHO Collaborating Centre consensus meeting on anti-cytokine therapy in rheumatoid arthritisP Emery, J Y Reginster, T Appelboom, et al.
Pageof 32